Lynn Yoffee
Publisher and VP of News at BioWorld
Publisher and VP of News at BioWorld MedTech
Publisher for @BioWorld from @Clarivate, gardener, sci-fi geek, love to swim
Articles
-
Nov 14, 2024 |
bioworld.com | Lynn Yoffee
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
-
Aug 30, 2018 |
bioworld.com | Lynn Yoffee
-
Jun 7, 2017 |
linkedin.com | Lynn Yoffee
-
Sep 1, 2016 |
bioworld.com | Lynn Yoffee
-
Jul 28, 2016 |
bioworld.com | Lynn Yoffee
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 1K
- Tweets
- 1K
- DMs Open
- No
Here’s a story about @Regeneron’s Eylea, a grandfather, a journalist and how @BioWorld plays a part in the #drugdiscovery cycle to improve human health #drugdiscovery #drugdevelopment #Biotech #Pharma @ClarivateHealth @ORandyO
From no hope to viable treatments, @BioWorld is there to cover the breakthroughs in medicine. Listen to @RandyOsborne explain why the @BioWorld team is ‘Always on the lookout for what's next.’ @Regeneron #drugdiscovery #drugdevelopment #Biotech #Pharma @ClarivateHealth https://t.co/CF8dh1MZod
In the 4th year of the COVID-19 pandemic ... biopharma's impact from @BioWorld, @Clarivate & @ClarivateHealth https://t.co/19eixBvn6k
“Ruth Bader Ginsburg is a cautionary tale.” via @NYTOpinion https://t.co/tYO0yuojA4